Oculomotor function in multiple system atrophy: clinical and laboratory features in 30 patients.
about
The diagnostic value of saccades in movement disorder patients: a practical guide and reviewOculo-Visual Dysfunction in Parkinson's Disease.Alterations of eye movement control in neurodegenerative movement disorders.Slowed Prosaccades and Increased Antisaccade Errors As a Potential Behavioral Biomarker of Multiple System Atrophy.Internuclear and supranuclear disorders of eye movements: clinical features and causes.What features improve the accuracy of the clinical diagnosis of progressive supranuclear palsy-parkinsonism (PSP-P)?Dorsal root ganglionopathy is responsible for the sensory impairment in CANVAS.Visual signs and symptoms of progressive supranuclear palsy.Vertical supranuclear gaze palsy in Niemann-Pick type C disease.Visual signs and symptoms of multiple system atrophy.Diagnosis and differential diagnosis of MSA: boundary issues.Fragile X-associated tremor/ataxia syndrome: phenotypic comparisons with other movement disorders.Pathologic correlates of supranuclear gaze palsy with parkinsonism.Visual signs and symptoms of corticobasal degeneration.Autonomic dysfunction is a major feature of cerebellar ataxia, neuropathy, vestibular areflexia 'CANVAS' syndrome.The Retina in Multiple System Atrophy: Systematic Review and Meta-Analysis.Impaired oculomotor function in a community-based patient population with newly diagnosed idiopathic parkinsonism.Vestibular Deficits in Neurodegenerative Disorders: Balance, Dizziness, and Spatial Disorientation.Potential clinical utility of multiple system atrophy biomarkers.Diagnosis of multiple system atrophy.Patterns of Eye Movement Impairment Correlate with Regional Brain Atrophy in Neurodegenerative Parkinsonism.Postural instability, frontotemporal dementia, and ophthalmoplegia: clinicopathological case.Multiple System Atrophy: An Oligodendroglioneural Synucleinopathy.Progressive parkinsonism, oculomotor abnormalities and autonomic dysfunction: clinicopathological case.
P2860
Q26770778-7AC93C5B-69DF-4DD5-818B-4977568B22E7Q27691337-7CC52F1D-6C54-4873-A439-7ED5E1046CD7Q30436300-1AD22E04-2301-4BAC-B67D-F52EB8C203A3Q33813931-7EB435CC-5BC5-4A48-96B8-5D79CE26A177Q37590404-DC3303B0-5E64-4AFE-A77D-589098F1281EQ37682763-810304A5-D6BC-4DA4-8F14-866BEA5D8D3EQ37725881-342FDC06-13FC-4609-A215-95364068A5C7Q37772535-54B9C16C-DF4A-4EB4-9043-DA341B0ABA97Q38027335-A4A98635-EC09-4ECC-A190-AD72C30E3712Q38254318-40C2D275-96D6-4AFF-936A-FF95C9402214Q38348584-E09B62FE-25F9-4BC1-B8E1-A7B529E811F8Q38896237-3C46ADB8-BB8F-4528-BFCF-EA952CDFD34DQ38931415-CD167E32-BAE8-4659-92B5-33292E80FA1FQ38935142-1C94FAFA-7034-4316-B97D-85645E3E9432Q39128045-DE2C618A-F6CA-44AE-967F-505E7BD16461Q39360892-05BAF4DB-BCC1-470C-B316-A1B119B7D740Q43583704-A4A05D09-7EE9-4D92-8D79-8AA0BF6445C4Q46132906-8BB86727-BFAD-4641-B3CF-34B8CFB3E9EEQ47663712-182261A1-4771-4A99-BA4A-43C12BE82B31Q47665262-959F2C68-3905-497F-A89F-AA1755F410D4Q48277491-57211885-474A-4356-858F-6C6712F63481Q49050999-EFABD02D-B1CE-462D-A2E0-6CCD866BD25AQ49562668-25FABB46-A2F9-4CC6-A71B-670313BAAB74Q51874272-74D320A8-990E-4CA2-9555-EA8EDB48A870
P2860
Oculomotor function in multiple system atrophy: clinical and laboratory features in 30 patients.
description
2008 nî lūn-bûn
@nan
2008 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Oculomotor function in multipl ...... atory features in 30 patients.
@ast
Oculomotor function in multipl ...... atory features in 30 patients.
@en
Oculomotor function in multipl ...... atory features in 30 patients.
@nl
type
label
Oculomotor function in multipl ...... atory features in 30 patients.
@ast
Oculomotor function in multipl ...... atory features in 30 patients.
@en
Oculomotor function in multipl ...... atory features in 30 patients.
@nl
prefLabel
Oculomotor function in multipl ...... atory features in 30 patients.
@ast
Oculomotor function in multipl ...... atory features in 30 patients.
@en
Oculomotor function in multipl ...... atory features in 30 patients.
@nl
P2093
P2860
P356
P1433
P1476
Oculomotor function in multipl ...... atory features in 30 patients.
@en
P2093
Adolfo Bronstein
C David Marsden
Linda Luxon
Susan Daniel
Tim Anderson
P2860
P304
P356
10.1002/MDS.21999
P407
P577
2008-05-01T00:00:00Z